Zydus Lifesciences Limited — Fluticasone Exporter Profile
Indian Pharmaceutical Exporter · #4 for Fluticasone · $1.7M export value · DGFT Verified
Zydus Lifesciences Limited is the #4 Indian exporter of Fluticasone with $1.7M in export value and 93 verified shipments. Zydus Lifesciences Limited holds a 0.8% market share in Fluticasone exports across 8 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Fluticasone Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Fluticasone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $580.7K | 31 | 35.4% |
| PHILIPPINES | $409.6K | 20 | 25.0% |
| VIETNAM, DEMOCRATIC REP. OF | $276.3K | 15 | 16.8% |
| VIETNAM | $111.8K | 9 | 6.8% |
| KENYA | $96.6K | 5 | 5.9% |
| MEXICO | $65.2K | 3 | 4.0% |
| VIETNAM DEMOCRATIC REP OF | $28.9K | 3 | 1.8% |
| GUYANA | $22.7K | 2 | 1.4% |
| VIETNAM DEMOCRATIC REP. OF | $18.2K | 3 | 1.1% |
| YEMEN, DEMOCRATIC | $15.5K | 1 | 0.9% |
Zydus Lifesciences Limited exports Fluticasone to 11 countries. The largest destination is SRI LANKA accounting for 35.4% of Zydus Lifesciences Limited's Fluticasone shipments, followed by PHILIPPINES (25.0%) and VIETNAM, DEMOCRATIC REP. OF (16.8%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fluticasone from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SUNSHINE HEALTHCARE LANKA LIMITED | SRI LANKA | $503.6K | 27 |
| ZYDUS HEALTHCARE PHILIPPINES INC. | PHILIPPINES | $309.8K | 16 |
| HAPHARCO J.S.C. BRANCH | VIETNAM, DEMOCRATIC REP. OF | $242.0K | 16 |
| ABACUS PHARMA (AFRICA) LTD | KENYA | $83.6K | 4 |
| BEN TRE PHARMACEUTICAL JOINT STOCK | VIETNAM, DEMOCRATIC REP. OF | $79.1K | 4 |
| STATE PHARMACEUTICALS | SRI LANKA | $73.5K | 3 |
| ZYDUS HEALTHCARE PHILIPPINES INC | PHILIPPINES | $63.7K | 2 |
| HAPHARCO J S C BRANCH | VIETNAM | $54.3K | 4 |
| HAPHARCO J.S.C. BRANCH. | VIETNAM | $36.7K | 3 |
| ZYDUS HEALTHCARE PHILIPPINES INC., | PHILIPPINES | $36.1K | 2 |
Zydus Lifesciences Limited supplies Fluticasone to 18 buyers globally. The largest buyer is SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA), followed by ZYDUS HEALTHCARE PHILIPPINES INC. (PHILIPPINES) and HAPHARCO J.S.C. BRANCH (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fluticasone Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $145.4M worth of Fluticasone through 9,009 shipments from 239 suppliers to 123 countries, serving 664 buyers globally. Zydus Lifesciences Limited contributes $1.7M to this total, accounting for 0.8% of India's Fluticasone exports. Zydus Lifesciences Limited ships Fluticasone to 11 countries through 18 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Fluticasone Exports?
Zydus Lifesciences Limited's average Fluticasone shipment value is $17.9K per consignment, based on 93 shipments totaling $1.7M. The largest destination is SRI LANKA (35.4% of Zydus Lifesciences Limited's Fluticasone exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Fluticasone Exporters?
Zydus Lifesciences Limited ranks #4 among 239 Indian Fluticasone exporters with a 0.8% market share. The top 3 exporters are CIPLA LIMITED ($133.2M), HETERO LABS LIMITED ($4.5M), ZYDUS LIFESCIENCES LIMITED ($1.7M). Zydus Lifesciences Limited processed 93 shipments to 8 destination countries.
What Fluticasone Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FLUTICASONE NASAL SPRAY IP 50MCG (FLUTICONE)(FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY)(1'S) | $198.0K | 12 |
| FLUTICASONE NASAL SPRAY IP 50MCG (FLUTIC | $145.6K | 8 |
| FORAIR 250 (SALMETEROL & FLUTICASONE PRO | $87.5K | 4 |
| FORAIR 250 INHALER (SALMETEROL AND FLUTICASONE PROPIONATE INHALATION) 1X120MDI | $59.9K | 2 |
| FLUTICASONE (FLUTICONE NASAL SPRAY) (FLUTICASONE NASAL SPRAY IP 50 MCG) 1'S UNITSHIPMENT UNDER LUT.NO. AD240324091585Z | $52.9K | 2 |
| FLUTICONE NASAL SPRAY 12ML FLUTICASONEPROPIONATE AQUEOUS NASAL SPRAY 1 S UNDER UNDER LUT No AD020325002509K Dated 18 | $48.0K | 1 |
| FORAIR 250 INHALER CFC FREE (SALMETEROLAND FLUTICASONE PROPIONATE INHALER) 1X120MDI UNDER LUT NO.AD240323012473N DT.14.NOS | $47.2K | 2 |
| FORAIR 125 (SALMETEROL & FLUTICASONE PRO | $43.3K | 2 |
| FORAIR 250 INHALER CFC FREE(SALMETEROL AND FLUTICASONE PROPIONATE INHALER)(1X120MDI) | $41.1K | 2 |
| FORAIR 250 INHALER CFC FREE, PHIL SALMETEROL XINAFOATE AND FLUTICASONE PROPIONATE IN (1X120MDI) | $40.3K | 1 |
Zydus Lifesciences Limited exports 61 distinct Fluticasone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUTICASONE NASAL SPRAY IP 50MCG (FLUTICONE)(FLUTICASONE PRO with 12 shipments worth $198.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Zydus Lifesciences Limited Compare to Nearest Fluticasone Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $133.2M | 2,663 | 53 | $50.0K |
| 2 | HETERO LABS LIMITED | $4.5M | 112 | 4 | $40.5K |
| 4 | ZYDUS LIFESCIENCES LIMITED ★ | $1.7M | 93 | 8 | $17.9K |
| 5 | SAVA HEALTHCARE LIMITED | $1.1M | 711 | 7 | $1.5K |
| 3 | MEDISPRAY LABORATORIES PRIVATE LIMITED | $950.0K | 19 | 1 | $50.0K |
Zydus Lifesciences Limited ranks #4 among 239 Indian Fluticasone exporters. Average shipment value of $17.9K compared to the market average of $608.3K. The closest competitors by value are CIPLA LIMITED and HETERO LABS LIMITED.
Which Indian Ports Ship Fluticasone Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 2,008 | 22.3% |
| DELHI AIR | 1,273 | 14.1% |
| DELHI AIR CARGO ACC (INDEL4) | 1,244 | 13.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 982 | 10.9% |
| NHAVA SHEVA SEA (INNSA1) | 473 | 5.3% |
| Bombay Air | 426 | 4.7% |
| JNPT/ NHAVA SHEVA SEA | 342 | 3.8% |
| Delhi Air | 296 | 3.3% |
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Fluticasone Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Fluticasone, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluticasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluticasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 93 individual customs records matching Zydus Lifesciences Limited exporting Fluticasone, covering 61 formulations to 11 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 664+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluticasone Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Fluticasone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Fluticasone Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluticasone. For current shipment-level data, contact TransData Nexus.